未登录 分享 收藏
RESULTS OF A MULTICENTER PHASE 2 BASKET TRIAL EVALUATING THE EFFICACY OF TASURGRATINIB (E7090) IN PATIENTS WITH ADVANCED SOLID TUMORS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) GENE ALTERATION, INCLUDING THOSE WITH PRIMARY BRAIN TUMORS: FORTUNE STUDY 评估TASURGRATINIB（E7090）在具有成纤维细胞生长因子受体（FGFR）基因变异的晚期实体瘤患者（包括原发性脑肿瘤患者）中的疗效的多中心II期篮式试验结果：FORTUNE研究 Takahashi, Masamichi; Sudo, Kazuki; Matsubara, Junichi; Tsuchihashi, Kenji; Kinoshita, Ichiro; Takahashi, Masanobu; Chiba, Yohei; Kohsaka, Shinji; Sadachi, Ryo; Machida, Ryunosuke; Ichimura, Masahiko; Okuma, Hitomi Sumiyoshi; Anjo, Kenta; Kurishita, Kazumi; Nakamura, Kenichi; Yonemori, Kan 分享 收藏
Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer: A Case Report PALB2回复突变作为乳腺癌对尼拉帕利耐药机制的出现：一例病例报告 Kawamura, Maako; Tada, Hiroshi; Shirota, Hidekazu; Dobashi, Miki; Takenaga, Noriko; Yasojima, Hiroyuki; Harada-shoji, Narumi; Komine, Keigo; Nakamura, Kenichi; Miyashita, Minoru; Kawakami, Hisato 分享 收藏
分享 收藏
分享 收藏
Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiation therapy for locally advanced maxillary sinus cancer (JCOG1212): final analysis 顺铂超选择性动脉灌注联合同期放射治疗局部晚期上颌窦癌的剂量探索与疗效确证试验（JCOG1212）：最终分析 Shinomiya, Hirotaka; Matsuura, Kazuto; Onimaru, Rikiya; Ohkoshi, Akira; Saito, Yuki; Tachibana, Hiroyuki; Shiga, Kiyoto; Ueda, Tsutomu; Asada, Yukinori; Uemura, Hirokazu; Beppu, Takeshi; Seto, Akira; Yasumatsu, Ryuji; Nakahira, Mitsuhiko; Omura, Go; Asakage, Takahiro; Minami, Shujiro; Fujii, Takashi; Hirayama, Yuji; Yoshida, Daisuke; Nakamura, Kenichi; Sasaki, Keita; Mizusawa, Junki; Fukuda, Haruhiko; Homma, Akihiro; JCOG-HNCSG 分享 收藏
Predictive modeling of oncogenic RNA expression using DNA alterations: Insights from Asian rare cancer patients 基于DNA变异的致癌RNA表达预测建模：来自亚洲罕见癌症患者的见解 de Almeida, K. Y.; Okuma, H. S.; Imasa, M. S.; Voon, P-j.; Fen, S. H. Hwoei; Chen, T. w-w.; Yusak, S.; Ramachandran, R.; Abu Bakar, N.; Chen, M-h.; Nakamura, K.; Yonemori, K. 分享 收藏
分享 收藏
Factors influencing decision-making between surgery and chemoradiotherapy for esophageal carcinoma from the JCOG0502 Yamamoto, Shun; Kato, Ken; Daiko, Hiroyuki; Ito, Yoshinori; Kajiwara, Takeshi; Kojima, Takashi; Miyata, Hiroshi; Nakagawa, Satoru; Ueno, Masaki; Watanabe, Masaya; Tsunoda, Shigeru; Abe, Tetsuya; Nagatani, Yoshiaki; Okada, Morihito; Morita, Masaru; Sato, Takuji; Mizusawa, Junki; Nakamura, Kenichi; Kitagawa, Yuko 分享 收藏
Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510) Nishikawa, Tadaaki; Kakunaga, Shigeki; Tamura, Kenji; Ando, Masashi; Ozaki, Toshifumi; Kawai, Akira; Ueda, Takafumi; Kawasaki, Mamiko; Tomatsuri, Sawako; Okamura, Nobuko; Kamikura, Masahisa; Hamada, Akinobu; Yoshida, Akihiko; Hirakawa, Akihiro; Shibata, Taro; Nakamura, Kenichi; Yonemori, Kan 分享 收藏
Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial Dabrafenib和trametinib在BRAF V600E/R或non-V600 BRAF突变的晚期实体瘤患者中的给药 (BELIEVE，NCCH1901): 一项多中心，开放标签和单臂II期试验 Shimoi, Tatsunori; Sunami, Kuniko; Tahara, Makoto; Nishiwaki, Satoshi; Tanaka, Shota; Baba, Eishi; Kanai, Masashi; Kinoshita, Ichiro; Shirota, Hidekazu; Hayashi, Hideyuki; Nishida, Naohiro; Kubo, Toshio; Mamesaya, Nobuaki; Ando, Yayoi; Okita, Natsuko; Shibata, Taro; Nakamura, Kenichi; Yamamoto, Noboru 分享 收藏
A phase 2 trial of nivolumab monotherapy in rare cancer patients with mismatch repair deficiency or MSI-high: ROCK trial (NCCH1709) from MASTER KEY Project Tsuchihashi, Kenji; Okuma, Hitomi; Machida, Ryunosuke; Sadachi, Ryo; Hirakawa, Akihiro; Ariyama, Hiroshi; Kanai, Masafumi; Okita, Natsuko; Nakamura, Kenichi; Yonemori, Kan 分享 收藏
分享 收藏
分享 收藏
Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study Koyama, Takafumi; Shimizu, Toshio; Kojima, Yuki; Sudo, Kazuki; Okuma, Hitomi Sumiyoshi; Shimoi, Tatsunori; Ichikawa, Hitoshi; Kohsaka, Shinji; Sadachi, Ryo; Hirakawa, Akihiro; Yoshida, Akihiko; Ando, Reiko Makihara; Ueno, Toshihide; Yanagaki, Mitsuru; Matsui, Naoko; Nakamura, Kenichi; Yamamoto, Noboru; Yonemori, Kan 分享 收藏
分享 收藏
分享 收藏
A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial Chiba, Yohei; Sudo, Kazuki; Kojima, Yuki; Okuma, Hitomi; Kohsaka, Shinji; Machida, Ryunosuke; Ichimura, Masahiko; Anjo, Kenta; Kurishita, Kazumi; Okita, Natsuko; Nakamura, Kenichi; Kinoshita, Ichiro; Takahashi, Masanobu; Matsubara, Junichi; Kusaba, Hitoshi; Yonemori, Kan; Takahashi, Masamichi 分享 收藏
Oxaliplatin with FU plus BEV in elderly pts with metastatic colorectal cancer: a phase III trial of JCOG1018 (RESPECT) Takashima, Atsuo; Hamaguchi, Tetsuya; Mizusawa, Junki; Yasuhiro, Shimada; Nagashima, Fumio; Ando, Masahiko; Okamura, Shu; Shimomura, Manabu; Katsumata, Kenji; Shiozawa, Manabu; Takii, Yasumasa; Shiomi, Akio; Ootsu, Satoshi; Funakoshi, Tohru; Hirata, Rei; Yamamoto, Tetsu; Kotaka, Masahito; Katayama, Hiroshi; Nakamura, Kenichi; Kanemitsu, Yukihide 分享 收藏
Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial Ohba, Akihiro; Morizane, Chigusa; Ueno, Makoto; Kobayashi, Satoshi; Kawamoto, Yasuyuki; Komatsu, Yoshito; Ikeda, Masafumi; Sasaki, Mitsuhito; Okano, Naohiro; Furuse, Junji; Hiraoka, Nobuyoshi; Yoshida, Hiroshi; Kuchiba, Aya; Sadachi, Ryo; Nakamura, Kenichi; Matsui, Naoko; Nakamura, Yoshiaki; Okamoto, Wataru; Yoshino, Takayuki; Okusaka, Takuji 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
NEURO-ONCOLOGY.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏